论文部分内容阅读
目的:探讨脂必泰与他汀对冠心病血脂异常患者的疗效。方法:收集我院冠心病血脂异常的患者,分为:80例研究组(接受阿托伐他丁联合脂必泰治疗)和80例对照组(接受阿托伐他丁)。对比(1)两组治疗前后血脂水平。(2)两组治疗期间心绞痛、心悸人均发作次数。结果:(1)两组治疗前Ch、TG、LDL-C、HDL-C差异无统计学意义(P>0.05),两组治疗后Ch、TG、LDL-C、HDL-C差异有统计学意义(P<0.05)。(2)研究组和对照组治疗期间心绞痛、心悸人均发作次数分别为(0.4±0.5次、1.6±1.3次)、(1.2±0.4次、2.3±0.8次),差异有统计学意义(P<0.05)。结论:脂必泰与他汀对冠心病血脂异常患者的治疗疗效。
Objective: To investigate the efficacy of Lipid and statin in patients with dyslipidemia of coronary heart disease. Methods: Patients with coronary heart disease dyslipidemia were collected. They were divided into two groups: 80 study groups (receiving atorvastatin combined with lipidbital therapy) and 80 control group (receiving atorvastatin). Comparison (1) before and after treatment of blood lipid levels. (2) The average number of episodes of angina pectoris and palpitation in two groups during treatment. Results: (1) There was no significant difference in Ch, TG, LDL-C and HDL-C between the two groups before treatment (P> 0.05). The difference of Ch, TG, LDL-C and HDL- Significance (P <0.05). (2) The number of episodes of angina pectoris and palpitation in study group and control group were (0.4 ± 0.5 times, 1.6 ± 1.3 times), (1.2 ± 0.4 times, 2.3 ± 0.8 times) respectively, the difference was statistically significant (P < 0.05). Conclusion: Therapeutic effect of Lipid and statins on patients with dyslipidemia of coronary heart disease.